CD4+ T cells were purified by MACS sorting and were polarized to Th9 phenotype. ChIP was performed according to the protocol described in (25 (link)) with the following modifications: Chromatin was sheared using Micrococcal Nuclease (New England Biolabs) and Protein A Magnetic Beads (New England Biolabs) were used. Cell lysates were used for immunoprecipitation with anti-STAT5, anti-BCL6, anti-mono-methyl-Histone H3 lysine 4 (H3K4me1), and anti-pan-methyl-H3K9 (all from Cell Signaling Technology) and were compared to control IgG. One region of the Il9 promoter containing putative STAT5 and BCL6 binding sites as well as a region of the Bcl6 promoter containing putative STAT5 binding sites was amplified by SYBR Green qPCR (Applied Biosystems) and quantified in duplicate with the percentage of input method. The following primers were used: Il9 Promoter: Site 1 Fwd: ACTGAGTTCCAGACTCCCGT, Rev: GCCCAGCACAGAACTGAAGA; Site 2 Fwd: GGATCCTCAAGGCCAATGCT, Rev: ACACCTCTGAGAAGTCGCTC; Site 3 Fwd: ACAGAAGTGTGCTGTCTGGT; Rev: CCCCTTGAGCCACTGGATAC. Bcl6 Promoter: Site 1 Fwd: CTGCGGAGCAATGGTAAAGC, Rev: ATAATCACCTGGTGTCCGGC; Site 2 Fwd: CGAGGAGCCGAGTTTATGGG, Rev: GAGAGTGCGCTTTGCTTTCC; Site 3 Fwd: CGAATGACAGTCCCGACGAT, Rev: GCTTGGGATGCTCCTGTTGT.